US Market Report for Temporary Artificial Heart Replacement Devices 2018 Market Report; Launched via MarketResearchReports.com
SynCardia's CardioWest™ was the world's first FDA-approved total artificial heart. It received FDA approval in October 2004 following a ten-year pivotal clinical study. The CardioWest™ was originally designed as a permanent replacement heart, but was approved as a bridge-to-transplant device for patients dying due to irreversible end-stage biventricular failure in which both the left and right ventricles of their hearts are failing. SynCardia's CardioWest™ is now marketed as the SynCardia Total Artificial Heart™. As of 2017, SynCardia's Total Artificial Heart™...
View full press release